Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 4
2005 7
2006 2
2007 3
2008 4
2009 3
2010 4
2011 6
2012 3
2013 2
2014 3
2015 2
2016 4
2019 2
2020 1
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression.
Cheung IY, Cheung NV, Modak S, Mauguen A, Feng Y, Basu E, Roberts SS, Ragupathi G, Kushner BH. Cheung IY, et al. Among authors: ragupathi g. J Clin Oncol. 2021 Jan 20;39(3):215-226. doi: 10.1200/JCO.20.01892. Epub 2020 Dec 16. J Clin Oncol. 2021. PMID: 33326254 Free PMC article. Clinical Trial.
Carbohydrate vaccines as immunotherapy for cancer.
Slovin SF, Keding SJ, Ragupathi G. Slovin SF, et al. Among authors: ragupathi g. Immunol Cell Biol. 2005 Aug;83(4):418-28. doi: 10.1111/j.1440-1711.2005.01350.x. Immunol Cell Biol. 2005. PMID: 16033538 Review.
Antibody inducing polyvalent cancer vaccines.
Ragupathi G, Gathuru J, Livingston P. Ragupathi G, et al. Cancer Treat Res. 2005;123:157-80. doi: 10.1007/0-387-27545-2_7. Cancer Treat Res. 2005. PMID: 16211870 Review.
Deciphering structural elements of mucin glycoprotein recognition.
Borgert A, Heimburg-Molinaro J, Song X, Lasanajak Y, Ju T, Liu M, Thompson P, Ragupathi G, Barany G, Smith DF, Cummings RD, Live D. Borgert A, et al. Among authors: ragupathi g. ACS Chem Biol. 2012 Jun 15;7(6):1031-9. doi: 10.1021/cb300076s. Epub 2012 Apr 9. ACS Chem Biol. 2012. PMID: 22444368 Free PMC article.
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
Kahn RM, Ragupathi G, Zhou QC, Iasonos A, Kravetz S, Hensley ML, Konner JA, Makker V, Tew WP, Aghajanian C, Sabbatini PJ, O'Cearbhaill RE. Kahn RM, et al. Among authors: ragupathi g. Cancer Immunol Immunother. 2023 Jan;72(1):183-191. doi: 10.1007/s00262-022-03225-1. Epub 2022 Jul 2. Cancer Immunol Immunother. 2023. PMID: 35779095 Free PMC article.
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody.
Carrasquillo JA, Fine BM, Pandit-Taskar N, Larson SM, Fleming SE, Fox JJ, Cheal SM, O'Donoghue JA, Ruan S, Ragupathi G, Lyashchenko SK, Humm JL, Scher HI, Gönen M, Williams SP, Danila DC, Morris MJ. Carrasquillo JA, et al. Among authors: ragupathi g. J Nucl Med. 2019 Nov;60(11):1517-1523. doi: 10.2967/jnumed.118.222844. Epub 2019 May 3. J Nucl Med. 2019. PMID: 31053681 Free PMC article. Clinical Trial.
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery.
Rosenbaum E, Chugh R, Ryan CW, Agulnik M, Milhem MM, George S, Jones RL, Chmielowski B, Van Tine BA, Tawbi H, Elias AD, Read WL, Budd GT, Qin LX, Rodler ET, Hirman J, Weiden P, Bennett CM, Livingston PO, Ragupathi G, Hansen D, D'Angelo SP, Tap WD, Schwartz GK, Maki RG, Carvajal RD. Rosenbaum E, et al. Among authors: ragupathi g. Eur J Cancer. 2022 Nov;176:155-163. doi: 10.1016/j.ejca.2022.09.003. Epub 2022 Oct 8. Eur J Cancer. 2022. PMID: 36215947 Free PMC article. Clinical Trial.
53 results